A B S T R A C T The synthesis and release of human prolactin (hPRL) in the human fetus was assessed by radioimmunoassay analysis of the content and concentration of hPRL in 82 pituitary glands and the concentration of serum hPRL in 47 fetuses of gestational age 68 days to term. Fetal hPRL exhibited parallelism with the reference standard (Lewis 203-1). hPRL was detected by 68 days of gestation (10 wk), the earliest fetal pituitary gland studied; 8 out of 33 pituitaries had a prolactin (PRL) content above 2.0 ng between 10-15 wk gestation. The mean content of PRL in the pituitary gland increased sharply from 14.8±4.6 ng at 15-19 wk to 405±142 ng at 20-24 wk and 542±204 ng at 25-29 wk gestation. By term, the mean content was 2,039± 459 (range 493-3,689) and the mean concentration 15.9±2.4 ng/mg (range 7-20). There was a significant positive correlation (P < 0.001) between the hPRL and human growth hormone (hGH) content of fetal pituitary glands; at term the hPRL/hGH ratio was 1/290. The concentration of serum hPRL between 12 and 24 wk ranged from 2.9 to 67 ng/ml, mean 19.5±2.5 ng/ml (n = 41); by 26 wk fetal serum hPRL increased sharply and attained levels of 300-500 ng/ml in late gestation. At delivery, the mean plasma concentration of hPRL was 167±+14.2 ng/ml in 36 umbilical venous specimens and 111.8±12.3 ng/ml in the matched maternal venous specimens. No correlation between serum hPRL and the pituitary content or concentration of hPRL was demonstrable in 12 matched fetal specimens.
A B S T R A C T The synthesis and release of human prolactin (hPRL) in the human fetus was assessed by radioimmunoassay analysis of the content and concentration of hPRL in 82 pituitary glands and the concentration of serum hPRL in 47 fetuses of gestational age 68 days to term. Fetal hPRL exhibited parallelism with the reference standard (Lewis 203-1). hPRL was detected by 68 days of gestation (10 wk), the earliest fetal pituitary gland studied; 8 out of 33 pituitaries had a prolactin (PRL) content above 2.0 ng between 10-15 wk gestation. The mean content of PRL in the pituitary gland increased sharply from 14.8±4.6 ng at 15-19 wk to 405±142 ng at 20-24 wk and 542±204 ng at 25-29 wk gestation. By term, the mean content was 2,039± 459 (range 493-3,689) and the mean concentration 15 .9±2.4 ng/mg (range [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . There was a significant positive correlation (P < 0.001) between the hPRL and human growth hormone (hGH) content of fetal pituitary glands; at term the hPRL/hGH ratio was 1/290. The concentration of serum hPRL between 12 and 24 wk ranged from 2.9 to 67 ng/ml, mean 19 .5±2.5 ng/ml (n = 41); by 26 wk fetal serum hPRL increased sharply and attained levels of 300-500 ng/ml in late gestation. At delivery, the mean plasma concentration of hPRL was 167±+14.2 ng/ml in 36 umbilical venous specimens and 111.8±12.3 ng/ml in the matched maternal venous specimens. No correlation between serum hPRL and the pituitary content or concentration of hPRL was demonstrable in 12 matched fetal specimens.
In five anencephalic infants, umbilical venous hPRL levels were between 65 and 283 ng/ml. In two anencephalic infants, thyrotropin releasing factor (TRF) (200 Ag IV) evoked a rise in serum hPRL in one patient from 43 to 156 ng/ml at 30 min, and in the other from 65 to Dr. Aubert is recipient of a grant from the Swiss National Fund for Scientific Research.
Received for publication 6 December 1974 and in revised form 5 March 1975. 404 ng/ml at 120 min. In both patients, plasma thyroidstimulating hormone (TSH) rose from undetectable base-line levels to peak levels of 97 and 380 /U/ml, respectively. The pattern of change in serum hPRL in the human fetus contrasts sharply with that of serum hGH, luteinizing hormone, or follicle-stimulating hormone.
These observations in the fetus and in anencephalic infants suggest that the striking elevation of serum PRL in the fetus is neither mediated by a putative PRL releasing factor or by TRF, nor is a consequence of suppression or absence of PRL release inhibiting factor alone, as a functional hypothalamus is not required to attain the high PRL concentration at term. Several lines of evidence support the view that high plasma estrogen levels characteristic of gestation act directly on the fetal anterior hypophysis to stimulate PRL secretion or to sensitize the secretory mechanism of the lactotrope, increasing its responsiveness to other stimuli.
INTRODUCTION
Human pituitary prolactin (hPRL)1 only recently has been isolated and characterized (1, 2) and specific radioimmunoassays developed (3-6) even though many clinical, physiological, and histological observations had suggested the existence of a separate prolactin (PRL) in man (7) (8) (9) (10) (11) .
Little is known about the ontogenesis of hPRL. Its concentration in the maternal circulation increases strikingly during pregnancy; similarly, high PRL levels are present in umbilical cord blood at term (12 (15) (16) (17) and in the of late gestation sheep fetuses (18, 19) . Preliminary studies from this laboratory (20 provided evidence for the synthesis and release of pituitary PRL in man. The present communicatic scribes in more detail changes in the content of PI fetal pituitaries, an abrupt change in serum PRL d gestation, the relationship of these observations t going studies of the ontogenesis of other pituitary mones (21-24, and footnote 2), and the maturati hypothalamic control of pituitary function.
There are inherent limitations in measuring th( mone content of an endocrine gland and not its flu in the interpretation of serum PRL concentr without knowledge of its metabolic clearance r the fetus. In addition, other factors can affect tl sults including the accuracy of the assessment of age, the random nature of the fetal specimens ava unrecognized artifacts related to the state of tl tuses studied, and the possible episodic or pulsati cretion of PRL. onset of the mother's last menstrual period, or by both methods. The preparation of the extracts has been described (22) 25 .511, P < 0.001).
METHODS
The limit of sensitivity of the RIA ranged between 0.02-0.05 ng.
All maternal and fetal specimens in this study were examined for immunological identity with the hPRL reference preparation (Fig. 1) . The displacement curves obtained with serial dilutions of fetal pituitary extracts, fetal serum, anencephalic umbilical venous plasma, and maternal plasma at term were parallel to the standard curve prepared with the Lewis 203-1 hPRL preparation. Using a mixed heterologous radioimmunoassay for hPRL as described by Jacobs, Mariz, and Daughaday (4) similar parallelism was found. The between-assay coefficient of variation was 4.7% (in 16 assays using reference plasma no. 71-167: B/Bo~50%), the withinassay coefficient of variation, estimated by assaying the same reference plasma at least four times in duplicate in the same assay, was 4.3±1.4% (+SE) for six assays. hPRL did not displace ["I]hGH tracer bound to anti-hGH in the RIA for hGH. (Fig.  8) ; fetal serum GH reaches a peak concentration at midpregnancy and then decreases until term (22) . There is a significant negative correlation between serum GH and gestational age (P < 0.001), whereas there is a positive correlation for serum PRL with fetal age from day 160 to term.
Studies in anencephalic infants. The concentration of plasma hPRL in five anencephalic infants on the 1st and 2nd day of life (the absence of hypothalamic tissue was confirmed at postmortem in each case) was within the same range as for 36 normal newborns at delivery (Table II) . In contrast, the plasma GH levels were (Table III) . In contrast to the high basal value for plasma PRL, plasma thyroid-stimulating hormon (TSH) was less than 0.5 AU/ml in the zero time specimens; however, after TRF administration, there was a striking increase in plasma TSH.
DISCUSSION
The data presented herein indicate that the pituitary gland of the human fetus is able to synthesize, store, and secrete PRL early in gestation and are consistent with a progressive increase in secretion by the lactotropes during the last trimester of gestation. At term, the mean umbilical vein plasma concentration of PRL is higher than the mean maternal plasma level (Fig. 9 ).
Normal newborns ]st FIGURE 9 Comparison of the pattern of change of fetal and maternal plasma hPRL during gestation. On the right, plasma levels in normal and anencephalic newborns are compared with those of normal infants and adults (6) . Levels for maternal plasma PRL during gestation are indicated as a composite curve using data from this laboratory and from reference 12.
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The immunochemical properties of fetal PRL are not different from those of adult or standard PRL in the test systems used. There was strict parallelism when the fetal hormone was examined in serial dilutions using two different antibodies in two different radioimmunoassay systems. No heterogeneity of immunoreactive PRL, such as high molecular weight forms ("big PRL"), was detected in the umbilical plasma of one fetus after gel filtration on Sephadex G-100.3 Neither hGH nor hCS cross-reacted in the PRL radioimmunoassay.
The onset of PRL synthesis and storage in the fetal pituitary gland occurs early in gestation. Fetal PRL was detected in the pituitary gland of the youngest fetus studied (68 days of gestation) and in the following 40-day period of gestation 8 of 33 pituitary glands studied had a PRL content higher than 2.0 ng. From 115 days gestation all but two pituitary glands had detectable PRL and both the pituitary content and concentration increased significantly with gestational age.
These observations confirm earlier studies of Levina (13) , who reported an increase in PRL biological activity of fetal pituitary glands between 18-40 wk of gestation. Further, Pasteels, and coworkers (14) The pattern of change in the concentration of fetal serum PRL during gestation correlates overall with the increase in pituitary PRL content. However, no incremental changes in the concentration of serum PRL is observed between 88 and 165 days gestation, in contrast to the steadily increasing pituitary PRL content. The striking increase of serum PRL from 165 days to term is associated with a further increase of pituitary PRL content. The increase in fetal and maternal concentrations of serum hPRL show a similar general trend during gestation; however, serum hPRL appears to rise later and attains a higher mean level in the fetal than in the maternal circulation. There was a weak but significant correlation between fetal and maternal hPRL levels at term. Despite this similarity in the pattern of change, it is likely that the hPRL secretion in the mother and the fetus are independent and that there 'Garnier, P. E., M. L. Aubert, S. L. Kaplan, and M. M. Grumnbach. Unpublished data.
is no or limited placental tranfer of hPRL, but definitive data in man are lacking. There is evidence of the impermeability of the sheep placenta for PRL (30) . Recently, the transfer of labeled [I] hPRL from the maternal to the fetal circulation in the rhesus monkey has been shown to be less than 1% (31) . Indirect evidence of the lack of or limited placental transfer of hPRL in humans is the persistence of high hPRL levels in the newborn infant for several weeks (6, 32) .
The serum PRL levels in the five anencephalic infants and in three others reported by Hayek, Driscoll, and Warshaw (33) were comparable to those of normal newborn infants. This finding indicates that (a) a functional hypothalamus is not required to attain the high PRL levels at term, and (b) pituitary lactotropes, independent of hypothalamic control, apparently are responsive to gestational factors. The high PRL levels in the anencephalic infants, compared with those of normal children and adults, represent important evidence against the possibility that TRF or a putative human PRL releasing factor (PRF) are responsible for the late gestational PRL rise in the fetal circulation.
PRL secretion is known to be regulated by a tonic inhibitory mechanism of hypothalamic origin (34) . Removing (43) , is now well documented in man (44) (45) (46) ; however, there is no evidence that TRF is the hypothetical PRF. What are the mechanisms involved in the sharp rise of plasma PRL in the maternal and fetal circulations toward the end of gestation? Several aspects should be considered: (a) the modulation of the hypothalamic control of PRL in pregnant women, (b) the maturation of this control in the fetus, and (c) the influence of the gestational hormones on the hypothalamus and/or the pituitary gland of the fetus and the pregnant woman.
The progressive increase of plasma PRL concentration in the pregnant women could be due, at least in part, to the suppression of PIF secretion or blockade of its effect on the pituitary gland with concomitant hyperplasia of the pituitary lactotropes (47 (52, 53) and in vivo (54, 55) . Additional support is provided by the observation that during pregnancy in the rhesus monkey, in contrast to man, there is only a moderate rise in maternal estrogen levels (56) and only a modest and variable increase in plasma PRL (57) . Similarly, serum PRL increases only at the end of gestation in the ewe (58) and lamb fetus (18, 19) . This late rise in PRL values correlates with the increase of circulating estrogens which occurs closely related to term in the fetal and maternal circulation in sheep (59) .
Pregnancies with anencephalic fetuses are characterized by a striking reduction in the excretion of estriol in the maternal urine owing mainly to the diminished secretion by the fetal adrenals of 16 a-OH-dehydroepiandrosterone sulfate, the principal precursor of estriol in pregnancy (60, 61) . However, estradiol and estrone in the fetal circulation originate mainly from precursors secreted by the maternal adrenal cortex (60, 61) , therefore, the circulating levels of these two steroids in the fetus should not be greatly affected by anencephaly. This was recently demonstrated in one anencephalic infant in whom the high plasma concentrations of unconjugated 17 f-estradiol and estrone in umbilical cord blood were in the normal range (62 (21) (22) (23) (24) . In the case of hGH., although a GH release inhibiting factor or somatostatin has been described (63), the very low GH plasma levels usually found in anencephalic infants suggest that GH secretion in the fetus is primarily under the influence of a growth hormone releasing factor (GRF). Fig. 10 compares the pattern of change of pituitary content and serum concentration of PRL and hGH throughout gestation. We have postulated that the generally high serum levels of hGH observed in the fetus at midgestation are attributable to relatively unrestrained secretion of GRF (or lack of GIF), and that toward term the concentration of hGH in fetal serum decreases in response to maturation of inhibitory regulatory mechanisms (21, 22) . Phylogenetic studies from amphibia to mammals on the action of PRL indicate that it is the most versatile of all hormones (64) . In man, PRL appears to promote the growth and secretory capacity of the maternal mammary gland in concert with other hormones during pregnancy. However, the role of PRL in the development of the human fetus is unknown. Neither hPRL nor hGH appear to be critical rate-limiting factors in the growth of the human fetus since apituitary fetuses are of normal or near-normal size at birth (21, 65, 66 
